Stock Screener App

Frei -

Installieren

1.24

2.36% -0.03

after-market

Handel nachbörslich: 1.15 -0.09 -7.26%

Lyell Immunopharma Inc (LYEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lyell Immunopharma Inc-Aktie (LYEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	76.92% 0.003	0.013	0.025	0.027	0.065
Operating Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Operating Income/Loss	6.61% -55.58	-59.51	-59.04	-65.91	-62.56
Nonoperating Income/Loss	177.41% -5.092	6.578	8.186	2.015	-4.403
Income/Loss From Continuing Operations Before Tax	76.92% 0.003	0.013	0.025	0.027	0.065
Income/Loss From Continuing Operations After Tax	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Net Income/Loss	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Diluted Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Basic Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Diluted Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$77.28

2.02%

SMMT

$20.39

2.15%

UTHR

$382.77

1.58%

MRNA

$53.29

0.47%

BGNE

$208.03

0.38%

BNTX

$110.97

1.84%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters